Group 1: Report's Investment Rating on the Industry - Not provided in the given content Group 2: Core Viewpoints of the Report - Since 2024, there have been continuous catalysts on both the supply and demand sides of the chemical sector. The current "anti - involution" market adds to its momentum. The chemical convertible bond market is still promising in the future, with positive fundamentals, favorable debt - conversion measures, and the "asymmetry" of small - cap convertible bonds [1][15] Group 3: Summary According to Relevant Catalogs 1. Characteristics of Chemical Convertible Bonds - **Issued at the Cycle Peak**: Over half of the chemical convertible bonds were issued during the 2020 - 2021 chemical bull market, often at the end or after the bull market. This leads to high conversion prices, difficult price - downward revisions, and concerns about credit risks. Bonds issued at the cycle bottom also have their own disadvantages [16] - **Mostly Small - cap Bonds and Small - market - value Targets**: Chemical convertible bonds are mostly small - cap bonds under 1 billion yuan. Small - cap and high - rated bonds are more likely to become bull bonds due to factors such as the company's solvency, institutional investment preferences, and market conditions [17] - **Low Institutional Attention on Underlying Stocks**: The proportion of chemical stocks and convertible bonds in the overall public fund net worth is relatively low, indicating weak short - selling power and accumulating long - buying factors [20] - **Rapid and Short - lived Market**: For chemical targets with strong cyclical characteristics, the market is often rapid and short - lived. Convertible bonds in this category are cautious about forced redemptions to avoid losing debt - conversion opportunities [26] - **Positive Debt - conversion Measures**: Many bonds issued during the 200 - 2021 bull market are now approaching the put - back period, so chemical companies are more active in debt - conversion. "Downward revision" is a powerful debt - conversion tool for near - maturity convertible bonds [27] 2. How to Seize the Opportunities of Expectation Differences in Chemical Convertible Bonds - **From the Perspective of the Sector**: The chemical sector has low institutional attention, large expectation differences, and potential for excess returns. It is difficult to make sector - wide allocations due to product differentiation and small single - bond scale. Many conservative funds are restricted from participating [29] - **From the Perspective of Convertible Bond Characteristics**: Below 130 yuan, the bonds rely on the "willingness to promote conversion", and the "reason for the rise" is crucial. Above 130 yuan, they depend on the alpha of the underlying stock and the capital structure, and the non - forced redemption and reduction of the convertible bond balance can open up the upward price space [31] - **From the Fundamental Perspective**: The common differences in chemical companies are "sustainability, amplitude, and performance realization". The reasons include concerns about downstream acceptance of price increases and the potential restart of idle production lines. Currently, the market is in the first stage, and the third - quarter report and spot prices are important references [35] 3. Tracking Ideas at Present - **Low - valued Underlying Stocks + "Asymmetry" of Convertible Bonds**: This is a high - probability choice. For companies with losses or small profits in the 2024 annual report, PB(LF) is used for measurement; for companies with normal profits, PE quantiles are used. Attention should be paid to market liquidity and cycle bottom judgment [39] - **Low - inventory Varieties**: Varieties with low inventory are more likely to increase in price when affected by supply or demand changes. Some chemical convertible bond companies' products such as viscose filament, silicone DMC, etc., have relatively low inventory and high operating rates. Attention should be paid to subsequent catalysts [42] - **Layout in Growth Sectors**: With the emergence of new downstream industrial trends, many chemical companies are actively deploying new products, which can bring opportunities for "valuation expansion" and new demand. Attention should be paid to technological breakthroughs and performance realization [44] - **Select Targets with Bargaining Power**: Companies with simple main businesses and good industry structures, as well as those with technological or industrial - chain advantages, are more likely to benefit from price increases and cost advantages [45] - **Seek the Bottom - position Attributes of Large - cap Convertible Bonds of Leading Blue - chip Stocks**: In 2025, the scale of financial bonds has shrunk significantly, while the participation in convertible bond assets has increased. Funds are looking for large - scale, low - risk convertible bonds as bottom - position assets [48] - **Emphasize the Elasticity of Small - market - value and Small - cap Bonds**: The "shell resource value" has become prominent. Small - cap convertible bonds can bring good returns in a trending market, but their performance is affected by factors such as market liquidity, credit risks, and economic expectations [49]

2025 年 07 月 20 日 投资评级：看好（维持） 医药生物 行业走势图 -24% -12% 0% 12% 24% 36% 2024-07 2024-11 2025-03 医药生物 沪深300 数据来源：聚源 相关研究报告 《CXO 龙头中报业绩超预期，重点关 注板块后续行情 — 行 业 周 报 》 -2025.7.13 《艾伯维收购 Capstan，加码体内 CAR-T—行业周报》-2025.7.6 《多款减肥药亮相 2025 ADA，重点关 注 AMYR 与 ActRII 靶点—行业周报》 -2025.6.29 集采政策明确优化，继续推荐制药板块性机会 ——行业周报 | 余汝意（分析师） | 刘艺（联系人） | 聂媛媛（联系人） | | --- | --- | --- | | yuruyi@kysec.cn | liuyi1@kysec.cn | nieyuanyuan@kysec.cn | | 证书编号：S0790523070002 | 证书编号：S0790124070022 | 证书编号：S0790124050002 | 集采政策持续优化，仿创 pharma 有望估值重塑 集采政策优化基调明确， ...

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-052 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于设立合资公司的进展暨完成工商登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、交易概述 法定代表人：李传宝 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）广东 菲鹏生物有限公司（以下简称"菲鹏生物"）于 2025 年 1 月 3 日签署《原料试剂 孵化项目交易框架协议》，通过原料、试剂及解决方案定制化开发及资产、技术 许可及服务转让等一系列交易，双方有意将共同新发起设立的项目公司孵化成为 具备原料和试剂及解决方案供应、原料和试剂生产及自主研发能力的公司。具体 内容详见公司于 2025 年 1 月 7 日在上海证券交易所网站(www.sse.com.cn)披露 的《上海阿拉丁生化科技股份有限公司关于自愿披露签订战略合作框架协议暨设 立合资公司的公告》（公告编号：2025-00 ...

Core Viewpoint - Aladdin (688179.SH) plans to bid for an 81.96% stake in Kasma Holdings from the Chinese Academy of Sciences Holdings Co., Ltd. with a starting price of 202 million yuan, aiming to enhance market competitiveness through resource integration and sales channel expansion [1][3]. Group 1: Company Overview - Kasma Holdings, established in 2016, focuses on technology services, investment consulting, and research resource promotion, with projected revenues exceeding 160 million yuan in both 2023 and 2024, and net profits of 54.02 million yuan and 25.67 million yuan respectively [3]. - Aladdin is a domestic supplier of research reagents, covering high-end chemicals and life sciences through its "Aladdin" brand, with a projected sales revenue of 534 million yuan in 2024, representing a year-on-year growth of 32.44% [3]. Group 2: Auction Details - The auction for Kasma Holdings will consist of a free bidding period from July 7, 10:00 to 10:10, followed by a timed bidding period, with the final outcome remaining uncertain [3]. - If the bidding is successful, Aladdin will further strengthen its research service ecosystem; if unsuccessful, the company emphasizes that its existing business will not be significantly affected [3].

Group 1 - The implementation of new regulations for algorithmic trading has been officially launched, with detailed provisions on reporting, trading behavior, information systems, and high-frequency trading [3] - The Ministry of Housing and Urban-Rural Development emphasizes the importance of promoting stable and healthy development in the real estate market, urging local authorities to utilize regulatory policies effectively [4] - The Ministry of Finance has decided to implement measures regarding government procurement of certain medical devices imported from the EU, effective from July 6, 2025 [5] Group 2 - China Shipbuilding Industry Corporation has received approval for the absorption and merger of China Shipbuilding Heavy Industry Group, indicating a significant consolidation in the shipbuilding sector [9] - The U.S. President Trump announced new tariffs, with rates potentially ranging from 10% to 70%, set to take effect on August 1 [6] - India plans to impose retaliatory tariffs on the U.S. due to the impact of increased tariffs on automobiles and parts [6] Group 3 - Meituan and Alibaba have initiated a competitive subsidy campaign for the summer consumption season, offering significant discounts on food delivery services [10] - Hongxin Electronics plans to issue technology innovation bonds not exceeding 500 million yuan [11] - A number of companies, including *ST Zitian and Tianmao Group, are facing delisting risks and have received warnings regarding their stock status [12][13] Group 4 - The report from CITIC Securities highlights the acceleration of progress in the controllable nuclear fusion industry, driven by technological breakthroughs and supportive industrial policies [39] - CITIC Jiantou notes that Chinese innovative drug assets are gaining global recognition, with an increase in business development transactions expected in the coming years [38]

Group 1 - The company held its 24th meeting of the 4th Supervisory Board on July 4, 2025, to discuss important matters [2][3] - The Supervisory Board approved the proposal to participate in the auction for 81.96% equity of Kasma Holdings Co., Ltd. held by the Chinese Academy of Sciences Holdings Co., Ltd. [3][4] - The auction aims to expand the company's sales channels, integrate downstream resources, and enhance market competitiveness and profitability [3][15] Group 2 - The auction is for 81.96% equity of Kasma Holdings with a starting price of 201.989109 million yuan [8][10] - The auction will take place at the Beijing Property Exchange, with a two-phase bidding process scheduled for July 7, 2025 [14] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [10][12] Group 3 - The Chinese Academy of Sciences Holdings Co., Ltd. is the seller, a state-owned enterprise with a registered capital of 5.06703 billion yuan [11] - Kasma Holdings Co., Ltd. has a registered capital of 50 million yuan and engages in various investment and consulting activities [13] - The first major shareholder of Kasma Holdings is the Chinese Academy of Sciences Holdings, which holds 81.96% of the equity [13]

Mergers and Acquisitions - Aladdin announced its participation in the auction for 81.96% equity of Kasma Holdings, with a transfer base price of 202 million yuan, aiming to expand sales channels and integrate downstream resources [1] - *ST Baoshi received approval from the Ningxia State-owned Assets Supervision and Administration Commission for the acquisition of 100% equity of Ningxia Electric Power Investment New Energy Co., Ltd. through major asset replacement and cash payment [2] - Guotou Zhonglu disclosed a transaction plan to acquire 100% shares of China Electronic Engineering Design Institute through share issuance, with the specific transaction price yet to be determined [3] Shareholding Changes - MaiPu Medical announced that shareholder Tang Ying plans to reduce holdings by no more than 1% of the company's shares, totaling up to 665,100 shares [4] - Yue Wannianqing disclosed that a 10% shareholder, Hehe Investment, plans to reduce holdings by no more than 6% of the company's shares, totaling up to 4.8 million shares [5] - *ST Huawang announced that shareholder Wu Qun plans to reduce holdings by no more than 1.76% of the company's shares, totaling up to 15,414,300 shares [6] Regulatory Issues - Liuhua Co. received an administrative regulatory decision from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to fulfill obligations regarding the integrity of appointed directors and supervisors [7] - *ST Huike was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8][9] - Tuisijingang announced that two vice presidents were arrested for violating important information disclosure laws, but stated that this would not impact the company's normal operations [10]

Financial Performance - Whirlpool expects a net profit of approximately 205 million yuan for the first half of 2025, an increase of about 174 million yuan or approximately 559% year-on-year [2] - Chipmotion Technology anticipates a net profit between 138 million to 169 million yuan for the first half of 2025, representing a year-on-year growth of approximately 144.46% to 199.37% [2] Mergers and Acquisitions - China Shipbuilding's absorption merger with China Shipbuilding Industry Corporation has been approved by the Shanghai Stock Exchange, pending further regulatory approvals [3] - Guotou Zhonglu plans to acquire 100% of China Electronic Engineering Design Institute through a share issuance, which constitutes a major asset restructuring [4] Shareholder Actions - Aotewei's actual controllers plan to transfer 4.99% of the company's shares, totaling 15.75 million shares, due to personal funding needs [5] - Yaguang Technology's chairman has been placed under detention, but the company's operations remain normal [5] Industry Developments - Ningbo Port expects a 9.8% year-on-year increase in container throughput for the first half of 2025 [8] - Three Trees anticipates a net profit growth of 80.94% to 119.04% for the first half of 2025 [8] - Zhuhai Group expects a net profit increase of 50.97% to 75.23% for the first half of 2025 [8] Project Wins - Sanxing Medical's subsidiary has pre-qualified for a 306 million yuan project with Southern Power Grid [8] - Hopu Co., Ltd. has jointly won a 449 million yuan shared energy storage demonstration project [8] - Hongsheng Huayuan's subsidiary has pre-qualified for an 1.127 billion yuan project with Southern Power Grid [8]

Core Viewpoint - The company Aladdin (688179) is participating in the auction for an 81.96% stake in Kasma Holdings, which is being sold by the Chinese Academy of Sciences Holdings, with a starting price of 202 million yuan [1] Group 1: Company Overview - Aladdin is a comprehensive manufacturer of research reagents, covering high-end chemicals, life sciences, analytical chromatography, and materials science, while also offering a small amount of laboratory consumables [2] - The company has developed its own "Aladdin" brand for research reagents and "Chip Silicon Valley" brand for laboratory consumables, primarily relying on its e-commerce platform for online sales [2] Group 2: Financial Performance - Aladdin's sales revenue for 2022, 2023, and 2024 was 378 million, 403 million, and 534 million yuan respectively, showing a year-on-year increase [2] - In 2024, the company achieved a revenue growth of 32.44% and a net profit of 98.76 million yuan, up 15.07% year-on-year [2] - In the first quarter of 2025, Aladdin reported a revenue of 130 million yuan, a 32.2% increase year-on-year, with a net profit of 24.18 million yuan, up 41.35% year-on-year [2] Group 3: Industry Insights - According to the National Bureau of Statistics, China's R&D expenditure for 2024 is projected to be 3.613 trillion yuan, an 8.3% increase from the previous year, indicating stable growth in the sector [2] - The R&D expenditure intensity (R&D expenditure as a percentage of GDP) is 2.68%, which is an increase of 0.1 percentage points from the previous year [2] - The increase in R&D funding is expected to drive the sales of consumables like reagents, suggesting a long-term growth potential for the industry [2] Group 4: Strategic Moves - The transaction aims to broaden the company's sales channels, integrate downstream resources, and enhance market competitiveness and profitability, benefiting both the company and its investors [3] - The auction process consists of two bidding periods: a free bidding period and a timed bidding period, with specific time frames outlined for each [3]

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-051 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于参与竞拍喀斯玛控股有限公司股权的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据北京产权交易所公开披露的产权转让信息，中国科学院控股有限公 司（以下简称"中科院控股"）公开挂牌出售其持有的喀斯玛控股有限 公司（以下简称"喀斯玛控股"）81.96%的股权（以下简称"标的股权"）， 转让底价 20,198.9109 万元。 2025 年 7 月 4 日，上海阿拉丁生化科技股份有限公司（以下简称"公司"） 召开第四届董事会第四十次会议及第四届监事会第二十四次会议，审议 通过了《关于参与竞拍中国科学院控股有限公司持有的喀斯玛控股有限 公司 81.96%的股权的议案》，同意公司参与中科院控股所持标的股份的 竞拍（以下简称"本次交易"）。 本次交易不构成关联交易，亦不构成《上市公司重大资产重组 ...